Regenerative Medicine in Society: Interdisciplinary Perspectives

A new two-part Special Focus Issue from the leading MEDLINE-indexed journal Regenerative Medicine explores research and perspectives on key issues impacting innovation within the field.

Go to the profile of Regenerative Medicine
Nov 10, 2017
0
0
Upvote 0 Comment

Future Science Group (FSG) is excited to announce the release of a two-part Special Focus Issue of Regenerative Medicine entitled “Regenerative Medicine in Society: Interdisciplinary Perspectives”. This expansive collection offers perspectives on key social, ethical, policy and regulatory issues across many areas of the rapidly evolving field of regenerative medicine.

The Special Focus Issue has been guest edited by Achim Rosemann (University of Warwick, UK), Jan Barfoot and Clare Blackburn (both MRC Centre for Regenerative Medicine, University of Edinburgh, UK).

“This double special issue brings together almost 30 articles from leading interdisciplinary researchers on regenerative medicine innovation,” stated Rosemann. “It provides up-to-date insights into recent regulatory developments, challenges to international harmonization, new perspectives on cell and tissue banking as well as critical reflections on the marketing of stem cell therapies, among many other themes.”

Through the involvement of Barfoot and Blackburn, the European Commission-funded EuroStemCell project, which aims to educate the public on stem cells and their impact on society, has collaborated with Regenerative Medicine toward the publication of these issues.

“Regenerative medicine is firmly part of our society and so the opportunity to gain cross-disciplinary insights from the range of globally-recognized scholars in this Special Focus Issue is timely and welcome,” explained Barfoot.

“It is vital that it is not only academics but society as a whole who participates in the conversations surrounding regenerative medicine and stem cell research. We hope that this body of work will generate new relevant discussions and inform future decisions regarding regenerative medicine.”

The guest editors provide scene-setting forewords for both installments of the two-part Special Focus Issue, in which they discuss the importance of informing and engaging relevant stakeholders and how this Special Focus Issue aims to facilitate this. They subsequently provide an overview of the wide variety of work presented in each issue including original research, perspectives and commentaries.

Both forewords are free to read here:

Part I Foreword: http://bit.ly/2ggRStH

Part II Foreword: http://bit.ly/2jedV8T

Adam Price-Evans, Managing Commissioning Editor for Regenerative Medicine, commented: “While the field of regenerative medicine offers great promise for novel therapeutics, there are still issues that must be addressed to ensure safe, ethical and regulated translation of research from bench to bedside. I am delighted to announce the publication of this two-part Special Focus Issue as it offers perspectives on many key questions that must be answered for this field to flourish and ultimately improve the lives of patients around the world.”

View Parts I and II of “Regenerative Medicine in Society: Interdisciplinary Perspectives” here:

Part I: https://www.futuremedicine.com/toc/rme/12/6

Part II: https://www.futuremedicine.com/toc/rme/12/7

All articles published in Part I and II of the Special Focus Issue will be freely available to members of RegMedNet throughout November 2017.

You can gain access here: https://www.future-science-group.com/joinrmn_2sfi-rme-access-2017/

Go to the profile of Regenerative Medicine

Regenerative Medicine

Journal, Future Science Group

Regenerative Medicine is an award-winning peer-reviewed journal, in print and web formats. The journal provides a forum to address the important challenges and advances in stem cell research and regenerative medicine, delivering this essential information in concise, clear and attractive article formats. Among other indexing services Regenerative Medicine is listed by MEDLINE/Index Medicus, EMBASE/Excerpta Medica, Chemical Abstracts, Science Citation Index Expanded™ (SciSearch®), Emcare, Biological Abstracts, BIOSIS Previews, Biotechnology Citation Index®, Journal Citation Reports/Science Edition®, Scopus® with an Impact Factor of 2.786 (2014). Each issue contains expertly drafted Reviews, Original Research articles, Perspectives, Editorials, topical insight from international leaders in their field, and additional added-value content. The Senior Editor of the journal is Professor Chris Mason, University College London. You can find out more about Regenerative Medicine at our website (www.future-science-group.com/journalprofile/regenerative-medicine/), where you can find the aims and scope of the journal and details of our international editorial board.

No comments yet.